Clinical spectrum of dengue in pediatric age group: A study at tertiary care hospital by Mehta, Kirti et al.
Vol 7 | Issue 1 | January 2020 Indian J Child Health 19
Dengue fever (DF) is a benign syndrome caused by arthropod-borne viruses and is characterized by biphasic fever, myalgia or arthralgia, rash, leukopenia, and 
lymphadenopathy. Dengue shock syndrome (DSS) is a severe 
form and often fatal characterized by capillary permeability, 
abnormalities of hemostasis, and, in severe cases, a protein-losing 
shock syndrome which is thought to have an immunopathology 
basis [1].
Dengue is the most rapidly spreading mosquito-borne viral 
disease of humankind, with a 30-fold increase in global incidence 
over the past five decades. It is a major public health concern 
throughout the tropical and subtropical regions of the world. 
Almost half the world’s population lives in countries where dengue 
is endemic. According to the World Health Organization (WHO), 
about 50–100 million new dengue infections are estimated to occur 
annually in more than 100 endemic countries, with a steady increase 
in the number of countries reporting the disease. Approximately 
1.8 billion (>70%) of the population at risk for dengue worldwide 
live in member states of the WHO South-East Asia Region (SEAR) 
and Western Pacific region, which bear nearly 75% of the current 
global disease burden due to dengue. Of the 11 countries of SEAR, 
10 countries including India are endemic for dengue [2].
Over the past two decades, there has been a global increase 
in the frequency of DF, dengue hemorrhagic fever (DHF), and 
its epidemics, with a concomitant increase in disease incidence. 
Various factors responsible for the resurgence of dengue epidemic 
are as follows: (i) Unprecedented human population growth; 
(ii) unplanned and uncontrolled urbanization; (iii) inadequate 
waste management; (iv) water supply mismanagement; 
(v) increased distribution and densities of vector mosquitoes; 
(vi) lack of effective mosquito control which has increased 
movement and spread of dengue viruses and development 
of hyperendemicity, and (vii) deterioration in public health 
infrastructure [3]. “Dengue” is a Spanish altered word evolved 
from the roots in the Swahili language as “Ki-dinga” [4].
In dengue, complications such as plasma leakage, hemorrhage, 
and organ impairment are prevented by early case detection which 
can be done by clinical suspicion with laboratory evidence and early 
treatment. With early recognition and prompt treatment, dengue-
related morbidity and mortality can be reduced. A warning sign 
should be managed with fluid therapy according to clinical response. 
Several studies have previously analyzed the clinic-epidemiologic 
profile of dengue infection. In this study, we evaluated the laboratory-
confirmed dengue cases presenting to the emergency departments 
of tertiary care hospital in an urban setting for their clinical and 
hematological profile, management, and outcome.
MATERIALS AND METHODS
A prospective observational study was carried out at a tertiary care 
hospital from March 2017 to August 2018. Ethical clearance was 
taken from the Human Research Ethical Committee to conduct this 
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study. The study population included serologically confirmed dengue 
patients admitted to the pediatric ward. Informed and written consent 
was obtained from the parents/guardian of all patients included in the 
study after explanation. All the children up to 12 years with positive 
dengue test were included in this study. Children who were positive 
for malaria, meningitis, and enteric fever and patients without 
parental consent were excluded from the study.
All the probable cases with high-grade fever, rash, 
lymphadenopathy, hepatomegaly, feature of shock, or hemorrhage 
were admitted with a provisional diagnosis of dengue to the 
pediatric ward. During the study, 160 suspected dengue cases 
with fever were admitted. Serological confirmation was done 
either with positive NS1 antigen or IgM/IgG antibodies by rapid 
serology test kit or ELISA. All the clinical findings and laboratory 
tests (complete hemogram with hematocrit and platelets, total 
count, and serum glutamic-pyruvic transaminase) were registered 
with monitoring chart of the sign of plasma leakage (pleural 
effusion, ascites, raised hematocrit, bleeding, hypovolemic shock, 
and thrombocytopenia). Blood parameters were monitored every 
day until a remarkable improvement was seen clinically and 
hematologically. All the data were entered into Microsoft Excel 
sheet and p<0.05 was considered statistically significant.
RESULTS
In the present study, there were 9990 pediatric admissions 
during the study, and out of them, 105 cases below 12 years 
of age were diagnosed as dengue cases giving a prevalence of 
1.05%. Among them, 72.42% (75) were male and 28.57% (30) 
were female with a ratio of 2.5:1. The mean age was 7.5 years 
(range: 5 months–12 years). The most common age group was 
7–9 years and it was lesser in infants. The patients with DF were 
89 (84.7%), DHF was 14 (13.3%), and DSS was 2 (1.90%). The 
age group-wise distribution of dengue is shown in Table 1.
In the present study, dengue was more common in urban slums 
area with urban:rural ratio of 10.6:1. The majority of the cases of 
dengue (81%) occurred from August to January (post-monsoon). 
Of 105 seropositive patients, fever was present in all patients 
(100%), as shown in Table 2. The tourniquet test was positive in 
15.24% of dengue patients. The most common laboratory finding 
was thrombocytopenia (74%) followed by hemoconcentration 
(45.8%) and leukopenia (38.1%), as shown in Table 3. Total 
leukocyte count (TLC) <4000/mm3 was seen in 38.12% of 
cases, while 49.50% of cases had TLC of 4000–11,000/mm3 and 
remaining 12.38% of cases had TLC of >11,000/mm3.
In our study, a sign of plasma leakage like pleural effusion 
was present in 10.5% of cases, while ascites was present in 2.3% 
of patients. Majority (58%) of the patients had a positive dengue 
NS1 antigen test. Majority of the patients was presented in an 
early phase of dengue infection. The most common complication 
was disseminated intravascular coagulation (11.4%), while 
encephalopathy was mostly present in DSS, as shown in Table 4. 
In the present study, fluid therapy and symptomatic treatment 
were given in 87 (82.7%) cases and only symptomatic treatment 
Table 1: Age group‑wise dengue cases
Age group 
(years)
Dengue 
fever
Dengue 
hemorrhagic 
fever
Dengue 
shock 
syndrome
Total
0–3 13 (92.8%) 0 (0%) 1 (7.2%) 14
4–6 20 (87%) 3 (13%) 0 (0%) 23
7–9 30 (79%) 7 (18.4%) 1 (2.6%) 38
10–12 26 (86.7) 4 (13.3%) 0 (0%) 30
Total 89 14 2 105
Table 2: Clinical profile of dengue
Symptoms Number of patients (%)
Fever 105 (100)
Abdominal pain 76 (72.4)
Vomiting 71 (67.7)
Headache 75 (71.4)
Rash 30 (28.6)
Joint pain 27 (25.7)
Nausea 22 (20.9)
Difficulty in respiration 11 (10.5)
Retro-orbital pain 46 (43.8)
Abdominal distension 10 (9.6)
Petechiae/purpura/ecchymosis 13 (12.4)
Table 3: Distribution of signs and complications in DF, DHF, 
and DSS
Signs DF DHF DSS
Impaired consciousness 0 0 2 (100%)
Pallor (%) 24 (27) 12 (85.8) 2 (100)
Lymphadenopathy 1 (1.1%) 0 0
Icterus (%) 15 (16.7) 12 (85.8) 2 (100)
Rash (%) 12 (13.5) 14 (100) 2 (100)
Petechiae (%) 1 (1.1) 13 (92.09) 2 (100)
Purpura (%) 1 (1.1) 6 (40) 2 (100)
Hepatomegaly 32 10 2
Splenomegaly 5 3 1
Platelet count
≤20,000/mm3 0 0 1
20,000–50,000/mm3 4 4 1
50,000–100,000/mm3 37 9 0
100,000–150,000/mm3 22 1 0
Normal platelet count 26 0 0
DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome, DF: Dengue fever
Table 4: Complications wise distribution
Complications Number of patients (%)
Disseminated intravascular coagulation 12 (11.4)
Pleural effusion 11 (10.5)
Ascites 3 (2.3)
Encephalopathy 2 (4.8)
Raised hematocrit 48 (45.80)
was given in 18 (13.1%) cases. The majority of patients were 
discharged successfully, while 0.95% of cases expired.
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DISCUSSION
In the present study, dengue accounted for 1.05% of pediatric 
admissions. These results were in accordance to the study 
conducted by Raj et al. [5]. The highest percentage of dengue 
admissions in the present study was noticed in >7 years of age 
group and lowest admissions in <3 years of age group, which is 
comparable with the study by Banerjee et al. [6]. In the present 
study, the male-to-female ratio was 2.5:1. Male predominance was 
also reported by Pai et al. and was explained by the traditional full 
covering of the skin surface in females as compared to males and 
more exposure of the male children to mosquitoes while playing 
outside in open fields [7].
In the present study, majority of the cases were 
classified into DF, and similar findings were also reported by 
Rathod et al. [10]. In the present study, majority of the patients 
was from urban area and less number of patients was from rural 
area, while in a study by Kulkarni et al. [8] and Shewale [9], 
patients from rural area were also in good number. This could 
be due to majority of the nearby area being urban slums; lesser 
number of patients was coming from the remote area.
Males and females were equally distributed in DHF which 
was comparable with the results obtained by Rathod et al. [10]. 
Majority of patients belong to DF (84.7%) and similar pattern was 
also present in the study by Raj et al. [5]. In the study done by 
Ratageri et al. [11] and Prathyusha et al. [12], maximum number 
of patients were from DHF, while it was less in the present study 
as majority of patients were admitted at the stage of DF and 
so progression of disease was prevented by early initiation of 
treatment.
The common clinical manifestations were fever, vomiting, 
abdominal pain, headache, and rash, where fever was most 
common, headache was present in 71.4% of patients, and rash 
was reported in 28.6% of patients. Fever was a common feature 
in all patients with dengue infections in all studies. In the study 
by Raj et al., the second most common feature was headache 
followed by an equal number of patients with abdominal pain and 
vomiting. In the study by Vazhayil et al., themajority of patients 
had vomiting which was the third most common complaint in the 
present study. Mogra et al. reported 50% of the cases with rash. 
Retro-orbital pain reported here was also observed by Banerjee 
et al. and Vazhayil et al. [6,13,14].
In the present study, majority of the patients had a positive 
dengue NS1 antigen test. These results were in accordance to the 
observations made by Vazhayil et al. [13], while Mishra et al. 
reported a positive rapid diagnostic test in majority of the patients 
[15]. This was mainly as the majority of patients presented in 
the early phase of dengue infections. Thrombocytopenia was the 
most common laboratory finding in dengue patients noted here, 
which was comparable with the observations made by other 
authors [10-12]. A total of 82.9% of patients were administered 
fluid therapy and 13.1% with symptomatic treatment in the 
present study, and these results were comparable to the study by 
Sharma et al. [16]. Newer findings were that patients in the study 
presented with retro-orbital pain along with fever.
This study had few limitations. The dengue cases that left 
without informing or took discharge against medical advice were 
excluded from the study as their investigations and outcome 
determination were not possible.
CONCLUSION
With an early diagnosis in initial stage and proper management, 
complications, morbidity, and mortality can be reduced. 
Moreover, community awareness and vector control measures 
need to be strengthened, especially during the peri-monsoon 
period to reduce dengue cases.
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